EB
Therapeutic Areas
Verge Genomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VRG50635 (VRG635) | Amyotrophic Lateral Sclerosis (ALS) | Phase 1 |
| Peripheral CD38 Program | Parkinson's Disease | Discovery |
| VRG201 | Obesity | Discovery |
| Target-03 | ALS | Discovery |
| Target-04 | ALS | Discovery |
| Unnamed Program | Frontotemporal Dementia | Discovery |